Penumbra Earnings
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
Penumbra earnings summary
Penumbra is scheduled to report Sep/2026 earnings on Nov 4, 2026. In its most recent report on Jul 30, 2026 (Q2 2026), PEN posted EPS of $0.88. Revenue for the quarter was $390.0 million.
Quarterly EPS is down 23.5% from the same quarter a year earlier. Across the last 16 reports, PEN shares moved an average of 3.6% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
PEN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $0.88 | — | +1.1% |
| May 6, 2026 | — | $0.82 | — | +0.0% |
| Feb 25, 2026 | — | $1.20 | — | -1.7% |
| Nov 5, 2025 | — | $1.17 | — | +5.2% |
| Jul 29, 2025 | — | $1.15 | — | -1.0% |
| Apr 23, 2025 | — | $1.00 | — | -1.3% |
| Feb 18, 2025 | — | $0.88 | — | -2.1% |
| Oct 30, 2024 | — | $0.75 | — | +1.4% |
| Jul 30, 2024 | — | $-1.55 | — | -3.1% |
| May 7, 2024 | — | $0.28 | — | -4.1% |
| Feb 22, 2024 | — | $1.38 | — | -0.7% |
| Nov 2, 2023 | — | $0.23 | — | -8.3% |
| Aug 1, 2023 | — | $0.48 | — | -1.9% |
| May 2, 2023 | — | $0.22 | — | +3.3% |
| Feb 23, 2023 | — | $0.10 | — | -2.2% |
| Nov 3, 2022 | — | $-0.06 | — | +19.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.